|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2011-7-22
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Safety and efficacy of non-ergot dopamine agonists for the treatment of idiopathic restless legs syndrome have been shown in short-term trials. We did a prospective open-label extension of a 6-week, double-blind randomised trial to assess the safety, tolerability, and efficacy of rotigotine transdermal patch for up to 5 years in patients with restless legs syndrome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1474-4465
|
|
pubmed:author |
pubmed-author:BenešHeikeH,
pubmed-author:Ferini-StrambiLuigiL,
pubmed-author:FichtnerAndreasA,
pubmed-author:García-BorregueroDiegoD,
pubmed-author:HöglBirgitB,
pubmed-author:KohnenRalfR,
pubmed-author:OertelWolfgangW,
pubmed-author:PoeweWernerW,
pubmed-author:SP710 study group,
pubmed-author:SchollmayerErwinE,
pubmed-author:Stiasny-KolsterKarinK,
pubmed-author:TrenkwalderClaudiaC
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
710-20
|
|
pubmed:meshHeading |
pubmed-meshheading:21705273-Administration, Cutaneous,
pubmed-meshheading:21705273-Adolescent,
pubmed-meshheading:21705273-Adult,
pubmed-meshheading:21705273-Aged,
pubmed-meshheading:21705273-Double-Blind Method,
pubmed-meshheading:21705273-Female,
pubmed-meshheading:21705273-Follow-Up Studies,
pubmed-meshheading:21705273-Headache,
pubmed-meshheading:21705273-Humans,
pubmed-meshheading:21705273-Male,
pubmed-meshheading:21705273-Middle Aged,
pubmed-meshheading:21705273-Nasopharyngitis,
pubmed-meshheading:21705273-Prospective Studies,
pubmed-meshheading:21705273-Restless Legs Syndrome,
pubmed-meshheading:21705273-Severity of Illness Index,
pubmed-meshheading:21705273-Tetrahydronaphthalenes,
pubmed-meshheading:21705273-Thiophenes,
pubmed-meshheading:21705273-Time Factors,
pubmed-meshheading:21705273-Transdermal Patch,
pubmed-meshheading:21705273-Treatment Outcome,
pubmed-meshheading:21705273-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.
|
|
pubmed:affiliation |
Philipps-Universität, Marburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
